![Vito Palombella](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vito Palombella
Director/Board Member at
MOLECULAR PARTNERS AG
Net worth: 35 101 $ as of 2026-06-29
Profile
Vito J Palombella is currently Director at Molecular Partners, Inc., Independent Non-Executive Director at Molecular Partners AG since 2020, Advisor at Atlas Venture Advisors, Inc., and Chief Scientific Officer at TRIANA Biomedicines, Inc. since 2023.
Formerly, Dr. Palombella was Senior Director-Cell & Molecular Biology at Millennium Pharmaceuticals, Inc. from 1999 to 2000, Senior Director-Cell & Molecular Biology at LeukoSite, Inc., Director-Molecular Biology & Protein Chemistry at Bioverativ Therapeutics, Inc. from 2000 to 2004, Chief Scientific Officer & Executive VP at Infinity Pharmaceuticals, Inc. from 2015 to 2016, and Chief Scientific Officer at Surface Oncology, Inc. from 2016 to 2023.
Education includes undergraduate studies at Rutgers State University of New Jersey and graduate and doctorate degrees from New York University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-30 | 9,046 ( 0.02% ) | 35 101 $ | 2026-06-29 |
Vito Palombella active positions
| Companies | Position | Start |
|---|---|---|
| MOLECULAR PARTNERS AG | Director/Board Member | 2020-03-31 |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Director/Board Member | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Santi Therapeutics, Inc.
 Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Chief Tech/Sci/R&D Officer | 2023-08-31 |
Former positions of Vito Palombella
| Companies | Position | End |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2023-09-07 |
| INFINITY PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2016-01-21 |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 2003-12-31 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 2000-09-30 |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Corporate Officer/Principal | 1998-12-31 |
Training of Vito Palombella
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Santi Therapeutics, Inc.
Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Health Technology |
- Stock Market
- Insiders
- Vito Palombella
